The Danish government is putting pressure on the country’s DKr5.5tn (€737bn) pensions industry to invest more in the domestic ...
Novo Nordisk A/S (NYSE:NVO) is among the most profitable healthcare stocks to buy. On January 26, BMO Capital lifted the ...
There’s no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to ...
However, Novo Nordisk has a plan to get things back on track, and the company's oral Wegovy is part of that strategy. In ...
A play examining the meteoric rise of Danish weight-loss drug giant Novo Nordisk will premiere on Saturday at a theatre ‌outside ...
Thomas Rantzau, employee representative on the Board of Directors since 2018, has decided to pursue new opportunities outside Novo Nordisk A/S after 22 years of employment. Therefore, he steps down ...